Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis.
Liu Y, Zhao Y, Shukha Y, Lu H, Wang L, Liu Z, Liu C, Zhao Y, Wang H, Zhao G, Liang W, Fan Y, Chang L, Yurdagul A Jr, Pattillo CB, Orr AW, Aviram M, Wen B, Garcia-Barrio MT, Zhang J, Liu W, Sun D, Hayek T, Chen YE, Rom O.
Liu Y, et al. Among authors: pattillo cb.
Cell Rep. 2021 Jul 27;36(4):109420. doi: 10.1016/j.celrep.2021.109420.
Cell Rep. 2021.
PMID: 34320345
Free PMC article.